We support research across the
entire spectrum of medical sciences,in
universities and hospitals, in our own
units, centres and institutes in the UK,
and in our units in Africa.

Skip to content

Important announcement  |   Due to essential maintenance the Je-S System will be unavailable from 17:00 GMT on Thursday 21 March to 08:30 GMT Tuesday 26 March 2019. We apologise for any inconvenience this may cause.


MRC scientists discover unique tau filament structures in head-injury associated dementia

20 March 2019

MRC Laboratory of Molecular Biology researchers reveal atomic structures of the abnormal tau filaments associated with chronic traumatic encephalopathy, a head injury-associated neurodegenerative disease, differ in structure from those seen in Alzheimer’s disease.

Nine-month treatment regimen for multi-drug resistant tuberculosis is as effective as 20-months

13 March 2019

A nine to 11-month treatment regimen is as effective in treating multi-drug resistant tuberculosis (MDR-TB) as the 20 to 24-month regimen recommended in 2011 WHO guidelines, according to new research conducted by a team of researchers, including MRC scientists.

New genetic data on 50,000 UK Biobank participants made available to the global health research community

11 March 2019

A vast tranche of new UK Biobank genetic data becomes available to health researchers today, offering an unprecedented resource to enhance understanding of human biology and aid in therapeutic discovery.

FUNDING: Science areas

Researchers can apply for MRC grant funding at any time.


Sign up

email iconKeep up to date with our latest news

Follow MRC on Twitter

MRC Insight: blog